
Pavlos Msaouel/LinkedIn
Aug 3, 2025, 12:56
Pavlos Msaouel: Adaptive Subgroup Clustering for Personalized Dosing and Improved Outcomes
Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, shared a post on X about recent paper he and colleagues co-authored, published in Biometrics.
“New Bayesian Precision Medicine PGen I-II design just published in Biometrics.
It fuses early efficacy/toxicity with long-term outcomes and adaptively clusters subgroups to personalize dosing, beating designs that ignore heterogeneity.”
Title: Precision generalized phase I-II designs
Authors: Saijun Zhao, Peter F Thall, Ying Yuan, Juhee Lee, Pavlos Msaouel, Yong Zang
Read The Full Article Biometrics.
More posts featuring Pavlos Msaouel on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 3, 2025, 12:31
Aug 3, 2025, 12:29
Aug 3, 2025, 12:13
Aug 3, 2025, 11:58
Aug 3, 2025, 11:55
Aug 3, 2025, 11:47
Aug 3, 2025, 11:42